Literature DB >> 28631570

The effect of RCAN1 on the biological behaviors of small cell lung cancer.

Ningqiang Ma1, Weiwei Shen1, Hailin Pang1, Ning Zhang1, Hong Shi1, Jianlin Wang2, Helong Zhang1.   

Abstract

Bone is the third most common site of cancer metastasis. In total, 30%-40% of lung cancer cases can develop skeletal metastasis for which no effective therapy in clinic is available. RCAN1 (regulator of calcineurin 1) is an important regulator in angiogenesis which is vital to tumor growth. In this study, we investigated the changes of biological behaviors in SBC-5 and SBC-3 cells after the RCAN1 expression level was changed. Briefly, overexpression of RCAN1 significantly attenuated their malignancy, including decreased ability of proliferation, colony formation, migration, invasion, and bone adherence. Furthermore, the cell cycle progression was impeded. Although the opposite changes were observed in SBC-3 cells after the RCAN1 expression was suppressed by RNA interference, the apoptosis rate was not affected by the expression level of RCAN1 in these cells. So, our research revealed that RCAN1 was involved in the development of small cell lung cancer, and it might be a cancer-inhibiting gene for the formation of bone metastases in small cell lung cancer.

Entities:  

Keywords:  RCAN1; Small cell lung cancer; calcineurin; cancer-inhibiting gene; metastasis

Mesh:

Substances:

Year:  2017        PMID: 28631570     DOI: 10.1177/1010428317700405

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  7 in total

Review 1.  RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Authors:  Mengyi Lao; Xiaozhen Zhang; Hanshen Yang; Xueli Bai; Tingbo Liang
Journal:  Mol Med       Date:  2022-06-18       Impact factor: 6.376

2.  Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood.

Authors:  Naisi Zhao; Mengyuan Ruan; Devin C Koestler; Jiayun Lu; Carmen J Marsit; Karl T Kelsey; Elizabeth A Platz; Dominique S Michaud
Journal:  Epigenetics       Date:  2021-05-19       Impact factor: 4.528

3.  STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression.

Authors:  Wenjing Zhu; Dongya Sheng; Yiqun Shao; Qiang Zhang; Yu Peng
Journal:  Mol Cell Biochem       Date:  2022-01-24       Impact factor: 3.396

4.  NF-κB signaling pathway inhibition suppresses hippocampal neuronal apoptosis and cognitive impairment via RCAN1 in neonatal rats with hypoxic-ischemic brain damage.

Authors:  Hua Fang; Hua-Feng Li; Miao Yang; Ren Liao; Ru-Rong Wang; Quan-Yun Wang; Peng-Cheng Zheng; Fang-Xiang Zhang; Jian-Ping Zhang
Journal:  Cell Cycle       Date:  2019-05-03       Impact factor: 4.534

5.  Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer.

Authors:  Peng Chen; Jie Min; Hong Wu; Helong Zhang; Chaoli Wang; Guangguo Tan; Feng Zhang
Journal:  Oncol Lett       Date:  2020-12-20       Impact factor: 2.967

6.  Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients.

Authors:  Wen-Xiang Li; Jia-Jia Zheng; Gang Zhao; Chen-Tao Lyu; Wei-Qi Lu
Journal:  World J Surg Oncol       Date:  2021-04-07       Impact factor: 2.754

7.  RCAN1.4 suppresses the osteosarcoma growth and metastasis via interfering with the calcineurin/NFAT signaling pathway.

Authors:  Bao Huang; Zenghui Jiang; Saishuang Wu; Hao Wu; Xuyang Zhang; Jian Chen; Fengdong Zhao; Junhui Liu
Journal:  J Bone Oncol       Date:  2021-07-14       Impact factor: 4.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.